Skip to search formSkip to main contentSkip to account menu

AST 120

Known as: AST-120 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background Beside the phosphate binding effect, non-calcium non-aluminum phosphate binder, namely sevelamer hydrochloride (SH… 
2016
2016
Chronic kidney disease (CKD) is a crucial risk factor for cardiovascular disease (CVD), and combined CKD and CVD further… 
2012
2012
The oral adsorbent AST-120 has the potential to delay dialysis initiation and improve survival of patients on dialysis. We… 
2011
2011
BACKGROUND Removal of uraemic toxins by AST-120 (Kremezin(®)) decreases the progression of chronic kidney disease by reducing… 
2009
2009
It is important to consider a strategy to halt the development of cardiovascular disease (CVD) in patients with chronic kidney… 
2006
2006
Background: AST-120 is an orally administered adsorbent used in Japan for prolonging time to initiation of hemodialysis and… 
2003
2003
BACKGROUND Tryptophan (TRP), an essential amino acid, is bound mostly to albumin in plasma. However, it is reported that binding… 
2002
2002
Aims: The effect of oral adsorbent, AST-120, on the experimental renal disease induced by adriamycin, uninephrectomy and high… 
2002
2002
We evaluated the dose dependence of an oral adsorbent, AST-120, in 31 patients with early chronic renal failure (baseline serum…